BOOK
Transcatheter Closure of Patent Foramen Ovale, An Issue of Interventional Cardiology Clinics, E-Book
(2017)
Additional Information
Book Details
Abstract
This issue of Interventional Cardiology Clinics, edited by the series Editor-in-Chief, Dr. Matthew Price, will cover Transcatheter Closure of Patent Foramen Ovale. Some of the topics discussed in this issue include, but are not limited to, PFO and the Interatrial Septum: Clinical-Anatomic Correlations; Current Dataset for PFO Closure in Cryptogenic; Stroke: Randomized Clinical Trials and Observational Studies; PFO closure: Devices and Technique; Identification and quantification of PFO-mediated shunts: echocardiography and transcranial Doppler; PFO closure for Hypoxemia; and Imaging Assessment of the interatrial Septum for ASD and PFO closure, among others.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
INTERVENTIONAL CARDIOLOGY CLINICS | i | ||
Copyright | ii | ||
CONTRIBUTORS | iii | ||
EDITOR-IN-CHIEF | iii | ||
EDITOR | iii | ||
AUTHORS | iii | ||
CONTENTS | v | ||
Preface: Transcatheter Closure of Patent Foramen Ovale | v | ||
Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment | v | ||
Identification and Quantification of Patent Foramen Ovale–Mediated Shunts: Echocardiography and Transcranial Doppler | v | ||
Imaging Assessment of the Interatrial Septum for Transcatheter Atrial Septal Defect and Patent Foramen Ovale Closure | v | ||
Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies | vi | ||
Patent Foramen Ovale and Migraine Headache | vi | ||
Patent Foramen Ovale Closure for Hypoxemia | vi | ||
Transcatheter Closure of Patent Foramen Ovale: Devices and Technique | vi | ||
TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE | vii | ||
FORTHCOMING ISSUES | vii | ||
RECENT ISSUES | vii | ||
Preface:\rTranscatheter Closure of Patent Foramen Ovale | ix | ||
Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment | 487 | ||
KEY POINTS | 487 | ||
INTRODUCTION | 487 | ||
STROKE NOMENCLATURE AND CLASSIFICATION | 488 | ||
RISK OF PARADOXIC EMBOLISM SCORE | 489 | ||
Patent Foramen Ovale–Attributable Risk | 489 | ||
Risk of Paradoxic Embolism Score and Risk of Recurrent Stroke | 489 | ||
RANDOMIZED EVALUATION OF RECURRENT STROKE COMPARING PATENT FORAMEN OVALE CLOSURE TO ESTABLISHED CURRENT STANDARD OF CARE TR ... | 491 | ||
PATIENT SELECTION AND US FOOD AND DRUG ADMINISTRATION APPROVAL OF PATENT FORAMEN OVALE CLOSURE FOR CRYPTOGENIC STROKE | 492 | ||
SUMMARY | 492 | ||
REFERENCES | 492 | ||
Identification and Quantification of Patent Foramen Ovale–Mediated Shunts | 495 | ||
KEY POINTS | 495 | ||
INTRODUCTION | 495 | ||
GENERAL PRINCIPLES FOR DETECTION OF RIGHT-TO-LEFT SHUNTING BY ULTRASONOGRAPHY | 496 | ||
Contrast Agents | 496 | ||
Site of Contrast Injection (Antecubital vs Femoral) | 496 | ||
Provocation Maneuvers | 496 | ||
Criteria for Diagnosis of Intracardiac Right-to-Left Shunts | 497 | ||
DIAGNOSIS OF RIGHT-TO-LEFT SHUNT BY TRANSTHORACIC ECHOCARDIOGRAPHY | 497 | ||
Transthoracic Echocardiography Protocol for Detecting Right-to-Left Shunt | 497 | ||
Diagnostic Accuracy of Transthoracic Echocardiography for Detection of Intracardiac Right-to-Left Shunt | 497 | ||
Advantages and Disadvantages of Transthoracic Echocardiography for Detection of Intracardiac Right-to-Left Shunt | 498 | ||
PATENT FORAMEN OVALE IMAGING BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY | 498 | ||
Transesophageal Echocardiography Protocol for Detecting a Patent Foramen Ovale | 498 | ||
Diagnostic Accuracy of Transesophageal Echocardiography for Detection of Patent Foramen Ovale | 498 | ||
Advantages and Disadvantages of Transesophageal Echocardiography | 499 | ||
DIAGNOSIS OF INTRACARDIAC RIGHT-TO-LEFT SHUNT BY TRANSCRANIAL DOPPLER | 500 | ||
Transcranial Doppler Protocol for Detecting Intracardiac Right-to-Left Shunt | 501 | ||
Diagnostic Accuracy of Transcranial Doppler for Detecting Intracardiac Right-to-Left Shunts | 501 | ||
Advantages and Disadvantages of Transcranial Doppler for Detection of Intracardiac Right-to-Left Shunt | 501 | ||
OTHER DIAGNOSTIC MODALITIES FOR IDENTIFICATION AND QUANTIFICATION OF A PATENT FORAMEN OVALE | 502 | ||
SUMMARY AND RECOMMENDATIONS | 503 | ||
REFERENCES | 503 | ||
Imaging Assessment of the Interatrial Septum for Transcatheter Atrial Septal Defect and Patent Foramen Ovale Closure | 505 | ||
KEY POINTS | 505 | ||
INTRODUCTION | 505 | ||
ANATOMY OF THE INTERATRIAL SEPTUM AND COMMON DEFECTS | 506 | ||
Patent Foramen Ovale | 506 | ||
Atrial Septal Defect | 507 | ||
DIAGNOSTIC IMAGING OF THE INTERATRIAL SEPTUM BY TRANSTHORACIC ECHOCARDIOGRAPHY | 508 | ||
Agitated Saline Contrast Study | 511 | ||
PREPROCEDURAL IMAGING OF ATRIAL SEPTAL DEFECTS AND PATENT FORAMEN OVALE WITH TRANSESOPHAGEAL ECHOCARDIOGRAPHY | 511 | ||
Patent Foramen Ovale Assessment by Transesophageal Echocardiography | 511 | ||
Atrial Septal Defect Assessment by Transesophageal Echocardiography | 512 | ||
Three-Dimensional Transesophageal Echocardiography Assessment of the Interatrial Septum | 514 | ||
INTRAPROCEDURAL ECHOCARDIOGRAPHIC GUIDANCE FOR TRANSCATHETER DEVICE CLOSURE OF ATRIAL SEPTAL DEFECT AND PATENT FORAMEN OVALE | 515 | ||
Transesophageal Echocardiographic Guidance of Device Closure | 516 | ||
Intracardiac Echocardiography | 518 | ||
Technical approach to intracardiac imaging for patent foramen ovale or atrial septal defect closure | 518 | ||
Key intracardiac echocardiography assessments after device implantation | 519 | ||
ASSESSING FOR COMPLICATIONS OF ATRIAL SEPTAL DEFECT AND PATENT FORAMEN OVALE CLOSURE | 519 | ||
Echocardiographic Predictors of Device Erosion | 521 | ||
Postprocedure Follow-up Imaging | 522 | ||
SUMMARY | 522 | ||
REFERENCES | 523 | ||
Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke | 525 | ||
KEY POINTS | 525 | ||
INTRODUCTION | 525 | ||
STUDIES OF THE EFFICACY OF MEDICAL THERAPY | 525 | ||
OBSERVATIONAL STUDIES OF PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE | 526 | ||
OBSERVATIONAL STUDIES COMPARING DEVICE CLOSURE WITH MEDICAL THERAPY | 527 | ||
Meta-analyses | 528 | ||
Propensity-Matched Analyses | 528 | ||
RANDOMIZED CLINICAL TRIALS | 529 | ||
CLOSURE I | 529 | ||
PC TRIAL | 530 | ||
RESPECT TRIAL | 530 | ||
META-ANALYSIS OF CLINICAL TRIALS | 534 | ||
COST-EFFECTIVENESS | 535 | ||
RISK OF PARADOXICAL EMBOLISM DATABASE AND SCORE | 535 | ||
CURRENT STATE OF US FOOD AND DRUG ADMINISTRATION APPROVAL | 535 | ||
FUTURE DIRECTIONS | 536 | ||
SUMMARY | 536 | ||
REFERENCES | 536 | ||
Patent Foramen Ovale and Migraine Headache | 539 | ||
KEY POINTS | 539 | ||
INTRODUCTION | 539 | ||
MIGRAINE AND ITS ASSOCIATION WITH PATENT FORAMEN OVALE | 539 | ||
POTENTIAL PATHOLOGIC MECHANISMS OF PATENT FORAMEN OVALE AND MIGRAINE | 540 | ||
EVIDENCE FOR PATENT FORAMEN OVALE CLOSURE | 541 | ||
SUMMARY | 543 | ||
REFERENCES | 543 | ||
Patent Foramen Ovale Closure for Hypoxemia | 547 | ||
KEY POINTS | 547 | ||
INTRODUCTION | 547 | ||
PATENT FORAMEN OVALE AND HYPOXEMIA | 547 | ||
PATENT FORAMEN OVALE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 549 | ||
PATENT FORAMEN OVALE AND PULMONARY HYPERTENSION | 550 | ||
ROLE FOR PATENT FORAMEN OVALE CLOSURE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 550 | ||
PATENT FORAMEN OVALE AND SLEEP APNEA | 551 | ||
PATENT FORAMEN OVALE AND PLATYPNEA-ORTHODEOXIA | 552 | ||
PATENT FORAMEN OVALE AND PULMONARY ARTERIOVENOUS MALFORMATION | 553 | ||
SUMMARY | 553 | ||
REFERENCES | 553 | ||
Transcatheter Closure of Patent Foramen Ovale | 555 | ||
KEY POINTS | 555 | ||
INTRODUCTION | 555 | ||
PREPROCEDURE EVALUATION | 555 | ||
Workup for Cryptogenic Stroke | 555 | ||
Anatomic Evaluation by Transesophageal Echocardiography | 557 | ||
Contraindications | 558 | ||
PROCEDURAL APPROACH | 558 | ||
Venous Access | 558 | ||
Introducer sheath for device delivery | 558 | ||
Introducer sheath for intracardiac echocardiography | 558 | ||
Special scenarios | 558 | ||
Patent Foramen Ovale Crossing | 558 | ||
Occluder Deployment | 559 | ||
Amplatzer patent foramen ovale occluder | 559 | ||
Indication | 559 | ||
Device description | 559 | ||
Device sizing | 559 | ||
Device implantation | 561 | ||
Amplatzer multifenestrated (cribiform) septal occluder | 562 |